Recombinant flagellins with partial deletions of the hypervariable domain lose antigenicity but not mucosal adjuvancy
- PMID: 20102702
- DOI: 10.1016/j.bbrc.2010.01.077
Recombinant flagellins with partial deletions of the hypervariable domain lose antigenicity but not mucosal adjuvancy
Abstract
Flagellin contains conserved N/C domains for TLR5 binding to activate innate immunity and a middle hypervariable domain harboring the major antigenic epitopes. However, conflict results existed in the previous studies as to whether the hypervariable domain was involved in the cytokine production and adjuvancy of flagellin. Here we constructed three flagellin variants (designated as FliCDelta190-278, FliCDelta220-320, and FliCDelta180-400) with deletions in the hypervariable domain. Our data demonstrated that all deletion variants lost substantial antigenicity but not mucosal adjuvancy. Surprisingly, the variant with deletion of amino acids 220-320 (FliCDelta220-320) induced higher production of IL-8, MCP-1, and TNF-alpha, and showed higher mucosal adjuvancy than full-length FliC flagellin. Our data supported the notion that the hypervariable domain was involved in the cytokine production by flagellin and more importantly demonstrated that the hypervariable domain was important for the mucosal adjuvancy of flagellin.
Copyright (c) 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Recombinant flagellins with deletions in domains D1, D2, and D3: Characterization as novel immunoadjuvants.Vaccine. 2019 Jan 21;37(4):652-663. doi: 10.1016/j.vaccine.2018.12.009. Epub 2018 Dec 21. Vaccine. 2019. PMID: 30583910
-
CD8+ T cell adjuvant effects of Salmonella FliCd flagellin in live vaccine vectors or as purified protein.Vaccine. 2010 Feb 3;28(5):1373-82. doi: 10.1016/j.vaccine.2009.11.003. Epub 2009 Nov 21. Vaccine. 2010. PMID: 19932669
-
Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice.Vaccine. 2004 Sep 9;22(27-28):3797-808. doi: 10.1016/j.vaccine.2003.12.035. Vaccine. 2004. PMID: 15315861
-
Utilizing bacterial flagellins against infectious diseases and cancers.Antonie Van Leeuwenhoek. 2014 Feb;105(2):275-88. doi: 10.1007/s10482-013-0075-2. Epub 2013 Nov 26. Antonie Van Leeuwenhoek. 2014. PMID: 24276957 Review.
-
Flagellin as an adjuvant: cellular mechanisms and potential.J Immunol. 2010 Nov 15;185(10):5677-82. doi: 10.4049/jimmunol.1002156. J Immunol. 2010. PMID: 21048152 Free PMC article. Review.
Cited by
-
Flagellins of Salmonella Typhi and nonpathogenic Escherichia coli are differentially recognized through the NLRC4 pathway in macrophages.J Innate Immun. 2014;6(1):47-57. doi: 10.1159/000351476. Epub 2013 Jun 27. J Innate Immun. 2014. PMID: 23816851 Free PMC article.
-
Antigen replacement of domains D2 and D3 in flagellin promotes mucosal IgA production and attenuates flagellin-induced inflammatory response after intranasal immunization.Hum Vaccin Immunother. 2013 May;9(5):1084-92. doi: 10.4161/hv.23809. Epub 2013 Feb 1. Hum Vaccin Immunother. 2013. PMID: 23377752 Free PMC article.
-
Flagellin-rPAc vaccine inhibits biofilm formation but not proliferation of S. mutans.Hum Vaccin Immunother. 2016 Nov;12(11):2847-2854. doi: 10.1080/21645515.2016.1203496. Epub 2016 Jul 8. Hum Vaccin Immunother. 2016. PMID: 27392114 Free PMC article.
-
Activation of NLRC4 downregulates TLR5-mediated antibody immune responses against flagellin.Cell Mol Immunol. 2016 Jul;13(4):514-23. doi: 10.1038/cmi.2015.33. Epub 2015 Apr 27. Cell Mol Immunol. 2016. PMID: 25914934 Free PMC article.
-
Enhanced antigen processing of flagellin fusion proteins promotes the antigen-specific CD8+ T cell response independently of TLR5 and MyD88.J Immunol. 2011 Jun 1;186(11):6255-62. doi: 10.4049/jimmunol.1001855. Epub 2011 Apr 22. J Immunol. 2011. PMID: 21515787 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous